Mode
Text Size
Log in / Sign up
N/A N=29 Treatment

Adaptation To and Satisfaction With Contact Lens Wear In Myopic Young Adults

Myopia

Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Subjective Quality of Vision (QoV) — 6.1; 5.3; 4.7 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
daily disposable contact lens (Device)
Age
Pediatric, Adult · 17+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Jun 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Subjective Quality of Vision (QoV)
6.1; 5.3; 4.7
SECONDARY
Contact Lens Impact on Quality of Life (CLIQ)
4.1

Summary

The purpose of this study was to assess whether young adults could adapt to and achieve satisfaction with a daily disposable contact lens.

Eligibility Criteria

Inclusion Criteria

  • Is between 17 and 25 years of age (inclusive) and has full legal capacity to volunteer;
  • Has read and signed an information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Has a vertex corrected spherical equivalent distance refraction that ranges between - 0.75D to -6.00D in each eye;
  • Has astigmatism ≤ -0.75 DC in either eye, by refraction;
  • Be correctable to better than 0.20 logMAR in each eye by refraction;
  • Has habitually worn spherical soft contact lenses to correct for distance vision (i.e. no multifocal or monovision) for the past 3 months;
  • Is willing to wear contact lenses for at least 10 hours a day, 6 days a week while in the study;
  • Demonstrates an acceptable fit with the study lenses;
  • Has ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses.

Exclusion Criteria

  • Is participating in any concurrent clinical or research study;
  • Has a history of amblyopia;
  • Has TNO Stereoacuity worse than 120" arc / or Titmus worse than 100" arc;
  • Has any known active ocular disease and/or infection;
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  • Has known sensitivity to the diagnostic pharmaceutical (sodium fluorescein) to be used in the study;
  • Is pregnant, lactating or planning a pregnancy at the time of enrolment (verbal confirmation at the screening visit);
  • Is pseudophakic;
  • Has undergone refractive error surgery;
  • Has one of following experiences with MiSight lenses:
  • Is currently wearing MiSight lenses or
  • Has worn MiSight lenses for more than one week at any given time or
  • Has worn MiSight lenses for any more than 30 minutes in the past 30 days;
  • Has had orthokeratology treatment within the last 3 months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04857723). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search